Massive activation-induced cell death of alloreactive T cells with apoptosis of bystander postthymic T cells prevents immune reconstitution in mice with graft-versus-host disease

Blood

Volumn 94, Issue 2, 1999, Pages 390-400

  Brochu, Sylvie ^a   Rioux Massé, Benjamin ^a   Roy, Jean ^a   Roy, Denis Claude ^a   Perreault, Claude ^a  

^a MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAVALIN A; FAS ANTIGEN; FAS LIGAND;

ALLOIMMUNITY; ANIMAL CELL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CONTROLLED STUDY; GRAFT VERSUS HOST REACTION; HELPER CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; THYMUS;

EID: 0033566353     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.2.390     Document Type: Article

References (96)

1. Modigliani Y, Coutinho G, Burlen-Defranoux O, Coutinho A, Bandeira A: Differential contribution of thymic outputs and peripheral expansion in the development of peripheral T cell pools. Eur J Immunol 24:1223, 1994
2. Tanchot C, Rocha B: Peripheral selection of T cell repertoires: The role of continuous thymus output. J ExpMed 186:1099, 1997
3. Berzins SP, Boyd RL, Miller JF: The role of the thymus and recent thymic migrants in the maintenance of the adult peripheral lymphocyte pool. J Exp Med 187:1839, 1998
4. George AJ, Ritter MA: Thymic involution with ageing: Obsolescence or good housekeeping? Immunol Today 17:267, 1996
5. Rocha B, Dautigny N, Pereira P: Peripheral T lymphocytes: Expansion potential and homeostatic regulation of pool sizes and CD4/CD8 ratios in vivo. Eur J Immunol 19:905, 1989
6. Rocha B, Penit C, Baron C, Vasseur F, Dautigny N, Freitas AA: Accumulation of bromodeoxyuridine-labeled cells in central and peripheral lymphoid organs: Minimal estimates of production and turnover rates of mature lymphocytes. Eur J Immunol 20:1697, 1990
7. Sprent J, Schaefer M, Hurd M, Surh CD, Ron Y: Mature murine B and T cells transferred to SCID mice can survive indefinitely and many maintain a virgin phenotype. J Exp Med 174:717, 1991
8. Dejbakhsh-Jones S, Jerabek L, Weissman IL, Strober S: Extrathymic maturation of αβ T cells from hemopoietic stem cells. J Immunol 155:3338, 1995
9. Garcia-Ojeda ME, Dejbakhsh-Jones S, Weissman IL, Strober S: An alternate pathway for T cell development supported by the bone marrow microenvironment: Recapitulation of thymic maturation. J Exp Med 187:1813, 1998
10. Saito H, Kanamori Y, Takemori T, Nariuchi H, Kubota E, Takahashi-Iwanaga H, Iwanaga T, Ishikawa H: Generation of intestinal T cells from progenitors residing in gut cryptopatches. Science 280:275, 1998
11. Sato K, Ohtsuka K, Hasegawa K, Yamagiwa S, Watanabe H, Asakura H, Abo T: Evidence for extrathymic generation of intermediate T cell receptor cells in the liver revealed in thymectomized, irradiated mice subjected to bone marrow transplantation. J Exp Med 182:759, 1995
12. Clegg CH, Rulffes JT, Wallace PM, Haugen HS: Regulation of an extrathymic T-cell development pathway by oncostatin M. Nature 384:261, 1996
13. Dulude G, Brochu S, Fontaine P, Baron C, Gyger M, Roy DC, Perreault C: Thymic and extrathymic differentiation and expansion of T lymphocytes following bone marrow transplantation in irradiated recipients. Exp Hematol 25:992, 1997
14. Mackall CL, Gress RE: Pathways of T-cell regeneration in mice and humans: Implications for bone marrow transplantation and immunotherapy. Immunol Rev 157:61, 1997
15. Lapp WS, Ghayur T, Mendes M, Seddik M, Seemayer TA: The functional and histological basis for graft-versus-host-induced immunosuppression. Immunol Rev 88:107, 1985
16. Baker MB, Riley RL, Podack ER, Levy RB: Graft-versus-host-disease-associated lymphoid hypoplasia and B cell dysfunction is dependent upon donor T cell-mediated Fas-ligand function, but not perform function. Proc Natl Acad Sci USA 94:1366, 1997
17. Hakim FT, Mackall CL: The immune system: Effector and target of graft-versus-host disease, in Ferrara JLM, Deeg HJ, Burakoff SJ (eds): Graft-vs.-Host Disease. New York, NY, Marcel Dekker, 1997, p 257
18. + T cell activation and IFN-γ production. J Immunol 161:2848, 1998
19. + progenitor cells mediate the antileukemic effect of donor lymphocyte infusions for relapsed chronic myeloid leukemia after allogeneic stem cell transplantation. Proc Natl Acad Sci USA 95:10152, 1998
20. Via CS, Nguyen P, Shustov A, Drappa J, Elkon KB: A major role for the Fas pathway in acute graft-versus-host disease. J Immunol 157:5387, 1996
21. Hattori K, Hirano T, Miyajima H, Yamakawa N, Tateno M, Oshimi K, Kayagaki N, Yagita H, Okumura K: Differential effects of anti-Fas ligand and anti-tumor necrosis factor a antibodies on acute graft-versus-host disease pathologies. Blood 91:4051, 1998
22. Lynch DH, Ramsdell F, Alderson MR: Fas and FasL in the homeostatic regulation of immune responses. Immunol Today 16:569, 1995
23. Suzuki I, Fink PJ: Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand. J Exp Med 187:123, 1998
24. Blazar BR, Korngold R, Vallera DA: Recent advances in graft-versus-host disease (GVHD) prevention. Immunol Rev 157:79, 1997
25. Yu XZ, Martin PJ, Anasetti C: Role of CD28 in acute graft-versus-host disease. Blood 92:2963, 1998
26. Fukushi N, Arase H, Wang B, Ogasawara K, Gotohda T, Good RA, Onoe K: Thymus: A direct target tissue in graft-versus-host reaction after allogeneic bone marrow transplantation that results in abrogation of induction of self-tolerance. Proc Natl Acad Sci USA 90:6301, 1990
27. Thomas JA, Sloane JP, Imrie SF, Ritter MA, Schuurman HJ, Huber J: Immunohistology of the thymus in bone marrow transplant recipients. Am J Pathol 122:531, 1986
28. Muller-Hermelink HK, Sale GE, Borisch B, Storb R: Pathology of the thymus after allogeneic bone marrow transplantation in man. A histologic immunohistochemical study of 36 patients. Am J Pathol 129:242, 1987
29. + T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 332:143, 1995
30. + T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. Blood 89:3700, 1997
31. Hakim FT, Cepeda R, Kaimei S, Mackall CL, McAtee N, Zujewski J, Cowan K, Gress RE: Constraints on CD4 recovery postchemotherapy in adults: Thymic insufficiency and apoptotic decline of expanded peripheral CD4 cells. Blood 90:3789, 1997
32. Roux E, Helg C, Dumont-Girard F, Chapuis B, Jeannet M, Roosnek E: Analysis of T-cell repopulation after allogeneic bone marrow transplantation: Significant differences between recipients of T-cell depleted and unmanipulated grafts. Blood 87:3984, 1996
33. + T cells in allogeneic bone marrow transplantation recipients. J Immunol 157:5739, 1996
34. Ottinger HD, Beelen DW, Scheulen B, Schaefer UW, Grosse-Wilde H: Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow. Blood 88:2775, 1996
35. Rooney CM, Smith CA, Ng CY, Loftin SK, Sixbey JW, Gan Y, Srivastava DK, Bowman LC, Krance RA, Brenner MK, Heslop HE: Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood 92:1549, 1998
36. Walter EA, Greenberg PD, Gilbert MJ, Finch RJ, Watanabe KS, Thomas ED, Riddell SR: Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med 333:1038, 1995
37. O'Reilly RJ, Small TN, Papadopoulos E, Lucas K, Lacerda J, Koulova L: Biology and adoptive cell therapy of Epstein-Barr virus-associated lymphoproliferative disorders in recipients of marrow allografts. Immunol Rev 157:195, 1997
38. Brochu S, Baron C, Hetu F, Roy DC, Perreault C: Oligoclonal expansion of CTLs directed against a restricted number of dominant minor histocompatibility antigens in hemopoietic chimeras. J Immunol 155:5104, 1995
39. Reap EA, Roof K, Maynor K, Borrero M, Booker J, Cohen PL: Radiation and stress-induced apoptosis: A role for Fas/Fas ligand interactions. Proc Natl Acad Sci USA 94:5750, 1997
40. Lefrancois L, Fuller B, Huleatt JW, Olson S, Puddington L: On the front lines: Intraepithelial lymphocytes as primary effectors of intestinal immunity. Springer Semin Immunopathol 18:463, 1997
41. Kumamoto T, Inaba M, Toki J, Adachi Y, Imamura H, Ikehara S: Cytotoxic effects of irradiation and deoxyguanosine on fetal thymus. Immunobiology 192:365, 1995
42. Antin JH, Ferrara JL: Cytokine dysregulation and acute graft-versus-host disease. Blood 80:2964, 1992
43. Hakim FT, Sharrow SO, Payne S, Shearer GM: Repopulation of host lymphohematopoietic systems by donor cells during graft-vetsus-host reaction in unirradiated adult F1 mice injected with parental lymphocytes. J Immunol 146:2108, 1991
44. Unutmaz D, Pileri P, Abrignani S: Antigen-independent activation of naive and memory resting T cells by a cytokine combination. J ExpMed 180:1159, 1994
45. Tough DF, Sprent J: Viruses and T cell turnover: Evidence for bystander proliferation. Immunol Rev 150:129, 1996
46. Ehl S, Hombach J, Aichele P, Hengartner H, Zinkernagel RM: Bystander activation of cytotoxic T cells: Studies on the mechanism and evaluation of in vivo significance in a transgenic mouse model. J Exp Med 185:1241, 1997
47. Tough DF, Sprent J: Turnover of naive-and memory-phenotype T cells. J Exp Med 179:1127, 1994
48. Sprent J, Tough DF: Lymphocyte life-span and memory. Science 265:1395,1994
49. Ryser JE, MacDonald HR: Limiting dilution analysis of alloantigen-reactive T lymphocytes. I. Comparison of precursor frequencies for proliferative and cytolytic responses. J Immunol 122:1691, 1979
50. Held W, Acha-Orbea H, MacDonald HR, Waanders GA: Superantigens and retroviral infection: Insights from mouse mammary tumor virus. Immunol Today 15:184, 1994
51. Aoki Y, Hiromatsu K, Usami J, Makino M, Igarashi H, Ogasawara J, Nagata S, Yoshikai Y: Clonal expansion but lack of subsequent clonal deletion of bacterial superantigen-reactive T cells in murine retroviral infection. J Immunol 153:3611, 1994
52. Savill J: Recognition and phagocytosis of cells undergoing apoptosis. Br Med Bull 53:491, 1997
53. Savill J: Apoptosis. Phagocytic docking without shocking. Nature 392:442, 1998
54. Philippe J, Louagie H, Thierens H, Vral A, Cornelissen M, De Ridder L: Quantification of apoptosis in lymphocyte subsets and effect of apoptosis on apparent expression of membrane antigens. Cytometry 29:242, 1997
55. Korngold R, Sprent J: Selection of cytotoxic T-cell precursors specific for minor histocompatibility determinants. I. Negative selection across H-2 barriers induced with disrupted cells but not with glutaraldehyde-treated cells: Evidence for antigen processing. J Exp Med 151:314, 1980
56. Korngold R, Sprent J: Negative selection of T cells causing lethal graft-versus-host disease across minor histocompatibility barriers. Role of the H-2 complex. J Exp Med 151:1114, 1980
57. Zarozinski CC, Welsh RM: Minimal bystander activation of CD8 T cells during the virus-induced polyclonal T cell response. J Exp Med 185:1629, 1997
58. + T cells during an acute virus infection. Immunity 8:167, 1998
59. Murali-Krishna K, Altman JD, Suresh M, Sourdive DJD, Zajac AJ, Miller JD, Slansky J, Ahmed R: Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection. Immunity 8:177, 1998
60. + T cells during the primary immune response to Epstein-Barr virus in vivo. J Exp Med 187:1395, 1998
61. Kuroda MJ, Schmitz JE, Barouch DH, Craiu A, Allen TM, Sette A, Watkins DI, Forman MA, Letvin NL: Analysis of Gag-specific cytotoxic T lymphocytes in simian immunodeficiency virus-infected rhesus monkeys by cell staining with a tetramenc major histocompatibility complex class I-peptide complex. J Exp Med 187:1373, 1998
62. Perillo NL, Pace KE, Seilhamer JJ, Baum LG: Apoptosis of T cells mediated by galectin-1. Nature 378:736, 1995
63. + T lymphocytes induced by CTLA-4 crosslinking. Proc Natl Acad Sci USA 95:10083, 1998
64. Van Parijs L, Abbas AK: Homeostasis and self-tolerance in the immune system: Turning lymphocytes off. Science 280:243, 1998
65. Van Parijs L, Peterson DA, Abbas AK: The Fas/Fas ligand pathway and bcl-2 regulate T cell responses to model self and foreign antigens. Immunity 8:265, 1998
66. Van Parijs L, Biuckians A, Abbas AK: Functional roles of fas and bcl-2-regulated apoptosis of T lymphocytes. J Immunol 160:2065, 1998
67. Martinez-Lorenzo MJ, Alava MA, Gamen S, Kim KJ, Chuntharapai A, Pineiro A, Naval J, Anel A: Involvement of APO2 ligand/TRAIL in activation-induced death of Jurkat and human peripheral blood T cells. Eur J Immunol 28:2714, 1998
68. Zheng L, Fisher G, Miller RE, Peschon J, Lynch DH, Lenardo MJ: Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377:348, 1995
69. Sytwu HK, Liblau RS, McDevitt HO: The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity 5:17, 1996
70. Refaeli Y, Van Parijs L, London CA, Tschopp J, Abbas AK: Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity 8:615, 1998
71. Ehl S, Hoffmann-Rohrer U, Nagata S, Hengartner H, Zinkernagel R: Different susceptibility of cytotoxic T cells to CD95 (Fas/Apo-1) ligand-mediated cell death after activation in vitro versus in vivo. J Immunol 156:2357, 1996
72. Zimmermann C, Rawiel M, Blaser C, Kaufmann M, Pircher H: Homeostatic regulation of CDS+ T cells after antigen challenge in the absence of Fas (CD95). Eur J Immunol 26:2903, 1996
73. Speiser DE, Sebzda E, Ohteki T, Bachmann MF, Pfeffer K, Mak TW, Ohashi PS: Tumor necrosis factor receptor p55 mediates deletion of peripheral cytotoxic T lymphocytes in vivo. Eur J Immunol 26:3055, 1996
74. Lohman BL, Razvi ES, Welsh RM: T-lymphocyte downregulation after acute viral infection is not dependent on CD95 (Fas) receptor-ligand interactions. J Virol 70:8199, 1996
75. + T cells induced by cross-presentation of self-antigens involves signaling through CD95 (Fas, apo-1). J Exp Med 188:415, 1998
76. + T cells creates double-negative cells in vivo. J Immunol 161:1686, 1998
77. Oehen S, Brduscha-Riem K: Differentiation of naive CTL to effector and memory CTL: Correlation of effector function with phenotype and cell division. J Immunol 161:5338, 1998
78. Booker JK, Reap EA, Cohen PL: Expression and function of fas on cells damaged by γ-irradiation in B6 and B6/lpr mice. J Immunol 161:4536, 1998
79. + CTL. J Immunol 159:2728, 1997
80. Ando K, Hiroishi K, Kaneko T, Moriyama T, Muto Y, Kayagaki N, Yagita H, Okumura K, Imawari M: Perforin, Fas/Fas ligand, and TNF-α pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL. J Immunol 158:5283, 1997
81. Homung F, Zheng L, Lenardo MJ: Maintenance of clonotype specificity in CD95/Apo-1/Fas-mediated apoptosis of mature T lymphocytes. J Immunol 159:3816, 1997
82. + cytotoxic T lymphocytes. J Virol 72:5948, 1998
83. Combadière B, Reis e Sousa C, Trageser C, Zheng LX, Kim CH, Lenardo MJ: Differential TCR signaling regulates apoptosis and immunopathology during antigen responses in vivo. Immunity 9:305, 1998
84. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233, 1991
85. Owen-Schaub LB, Yonehara S, Crump WL, Grimm EA: DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell Immunol 140:197, 1992
86. Moulian N, Bidault J, Planché C, Berrih-Aknin S: Two signaling pathways can increase Fas expression in human thymocytes. Blood 92:1297, 1998
87. Sayers TJ, Brooks AD, Lee JK, Fenton RG, Komschlies KL, Wigginton JM, Winkler-Pickett R, Wiltrout RH: Molecular mechanisms of immune-mediated lysis of murine renal cancer: Differential contributions of perforin-dependent versus Fas-mediated pathways in lysis by NK and T cells. J Immunol 161:3957, 1998
88. Levy RB, Jones M, Hamilton BL, Paupe J, Horowitz T, Riley R: IL-7 drives donor T cell proliferation and can costimulate cytokine secretion after MHC-matched allogeneic bone marrow transplantation. J Immunol 154:106, 1995
89. Krenger W, Hill GR, Ferrara JLM: Cytokine cascades in acute graft-versus-host disease. Transplantation 64:553, 1997
90. Liem LM, van Lopik T, van Nieuwenhuijze AE, van Houwelingen HC, Aarden L, Goulmy E: Soluble fas levels in sera of bone marrow transplantation recipients are increased during acute graft-versus-host disease but not during infections. Blood 91:1464, 1998
91. Carroll MC: The lupus paradox. Nat Genet 19:3, 1998
92. Rovere P, Vallinoto C, Bondanza A, Crosti MC, Rescigno M, Ricciardi-Castagnoli P, Rugarli C, Manfredi AA: Cutting edge: Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function. J Immunol 161:4467, 1998
93. Mevorach D, Zhou JL, Song X, Elkon KB: Systemic exposure to irradiated apoptotic cells induces autoantibody production. J Exp Med 188:387, 1998
94. Parkman R: Clonal analysis of murine graft-vs-host disease. I. Phenotypic and functional analysis of T lymphocyte clones. J Immunol 136:3543, 1986
95. Via CS, Shearer GM: T-cell interactions in autoimmunity: Insights from a murine model of graft-versus-host disease. Immunol Today 9:207, 1988
96. Siadak M, Sullivan KM: The management of chronic graft-versus-host disease. Blood Rev 8:154, 1994